Advanced Pharma CR, LLC   Report issue

For profit Phase 1
Founded: Miami FL United States (1992)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2013
NCT01948024
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Advanced Pharma CR LLC | Advanced Pharma CR, LLC

Active Ingredients

Drugs in Phase 1 Trials (5)

asenapine (saphris) (1 trial)

Cudetaxestat (1 trial)

epetraborole (1 trial)

nintedanib (ofev) (1 trial)

pirfenidone (esbriet) (1 trial)

Drugs in Other Trials (1)

axa4010 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 1)

Schizophrenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 6